{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:39:04Z","timestamp":1784093944776,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1902A"],"award-info":[{"award-number":["01GM1902A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["NV18-07-00283"],"award-info":[{"award-number":["NV18-07-00283"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk AS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmg.2021.104372","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T20:02:55Z","timestamp":1635451375000},"page":"104372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Management of cardiac aspects in children with Noonan syndrome \u2013 results from a European clinical practice survey among paediatric cardiologists"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4701-5843","authenticated-orcid":false,"given":"Cordula M.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Burkitt-Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Edouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixto","family":"Garc\u00eda-Mi\u00f1a\u00far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-5375","authenticated-orcid":false,"given":"Jan","family":"Lebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2316-3334","authenticated-orcid":false,"given":"Guftar","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Verloes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingegerd","family":"\u00d6stman-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ejmg.2021.104372_bib1","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","article-title":"Hypertrophic cardiomyopathy in noonan syndrome treated by MEK-inhibition","volume":"73","author":"Andelfinger","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104372_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1515\/JPEM.2002.15.6.851","article-title":"Growth hormone therapy in Noonan's syndrome: non-cardiomyopathic congenital heart disease does not adversely affect growth improvement","volume":"15","author":"Brown","year":"2002","journal-title":"J. Pediatr. Endocrinol. Metab. : JPEM (J. Pediatr. Endocrinol. Metab.)"},{"key":"10.1016\/j.ejmg.2021.104372_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0735-1097(93)90436-5","article-title":"Cardiologic abnormalities in Noonan syndrome - phenotypic diagnosis and echocardiographic assessment of 118 patients","volume":"22","author":"Burch","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejmg.2021.104372_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2017.07.068","article-title":"Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results","volume":"245","author":"Calcagni","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104372_bib5","first-page":"61.e61","article-title":"[Noonan syndrome: genetic and clinical update and treatment options]","volume":"93","author":"Carcavilla","year":"2020","journal-title":"Anales de pediatria (Barcelona, Spain : 2003)"},{"issue":"6","key":"10.1016\/j.ejmg.2021.104372_bib6","first-page":"2291","article-title":"The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome","volume":"81","author":"Cotterill","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejmg.2021.104372_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1472-6823-12-26","article-title":"Different thresholds of tissue-specific dose-responses to growth hormone in short prepubertal children","volume":"12","author":"Decker","year":"2012","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.ejmg.2021.104372_bib8","article-title":"Management of endocrine aspects of Noonan syndrome across Europe: a sub-analysis of a European clinical practice survey","author":"Edouard","year":"2021","journal-title":"Eur. J. Med. Genet."},{"issue":"39","key":"10.1016\/j.ejmg.2021.104372_bib9","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmg.2021.104372_bib10","article-title":"European Medical Education Initiative on Noonan Syndrome: a clinical practice survey assessing the diagnosis and clinical management of individuals with Noonan Syndrome across Europe","author":"Garc\u00eda-Mi\u00f1a\u00far","year":"2021","journal-title":"Eur. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104372_bib11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ajmg.a.36982","article-title":"Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog","volume":"167A","author":"Hahn","year":"2015","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104372_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.semtcvs.2018.12.004","article-title":"Early outcomes of cardiac surgery in patients with noonan syndrome","volume":"31","author":"Hemmati","year":"2019","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104372_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.athoracsur.2011.10.032","article-title":"Hypertrophic cardiomyopathy in childhood: disease natural history, impact of obstruction, and its influence on survival","volume":"93","author":"Hickey","year":"2012","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104372_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1747-0803.2010.00465.x","article-title":"Survival implications: hypertrophic cardiomyopathy in Noonan syndrome","volume":"6","author":"Hickey","year":"2011","journal-title":"Congenit. Heart Dis."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104372_bib15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/S1047951117002827","article-title":"Results of balloon pulmonary valvoplasty in children with Noonan's syndrome","volume":"28","author":"Holzmann","year":"2018","journal-title":"Cardiol. Young"},{"issue":"5","key":"10.1016\/j.ejmg.2021.104372_bib16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1253\/circj.69.536","article-title":"Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy","volume":"69","author":"Honda","year":"2005","journal-title":"Circ. J."},{"issue":"8","key":"10.1016\/j.ejmg.2021.104372_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1507\/endocrj.EJ19-0371","article-title":"Long-term efficacy and safety of two doses of Norditropin(\u00ae) (somatropin) in Noonan syndrome: a 4-year randomized, double-blind, multicenter trial in Japanese patients","volume":"67","author":"Horikawa","year":"2020","journal-title":"Endocr. J."},{"issue":"10","key":"10.1016\/j.ejmg.2021.104372_bib18","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/europace\/eux331","article-title":"Short atrioventricular delay pacing therapy in young and old patients with hypertrophic obstructive cardiomyopathy: good long-term results and a low need for reinterventions","volume":"20","author":"Javidgonbadi","year":"2018","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104372_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000963","article-title":"Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy","volume":"6","author":"Javidgonbadi","year":"2019","journal-title":"Open heart"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104372_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.6065\/apem.2016.21.1.26","article-title":"Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome","volume":"21","author":"Jeong","year":"2016","journal-title":"Annals of pediatric endocrinology & metabolism"},{"issue":"4","key":"10.1016\/j.ejmg.2021.104372_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1017\/S1047951110000260","article-title":"Progressively worsening hypertrophic cardiomyopathy in a child with newly diagnosed Costello syndrome while receiving growth hormone therapy","volume":"20","author":"Kobayashi","year":"2010","journal-title":"Cardiol. Young"},{"issue":"19 Suppl. l","key":"10.1016\/j.ejmg.2021.104372_bib22","first-page":"II144","article-title":"Elevated insulin-like growth factor-I and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism","volume":"98","author":"Li","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ejmg.2021.104372_bib23","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.96.3.874","article-title":"Overexpression of transforming growth factor-beta 1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy","volume":"96","author":"Li","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104372_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajmg.c.31765","article-title":"Congenital heart defects in Noonan syndrome: diagnosis, management, and treatment","volume":"184","author":"Linglart","year":"2020","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"6","key":"10.1016\/j.ejmg.2021.104372_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3476(99)70088-0","article-title":"Congenital heart diseases in children with Noonan syndrome: an expanded cardiac spectrum with high prevalence of atrioventricular canal","volume":"135","author":"Marino","year":"1999","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104372_bib26","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/01.CIR.89.4.1751","article-title":"Independent predictors of long-term results after balloon pulmonary valvuloplasty. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators","volume":"89","author":"McCrindle","year":"1994","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ejmg.2021.104372_bib27","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000124723.16433.31","article-title":"Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy","volume":"109","author":"McMahon","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ejmg.2021.104372_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejmg.2021.104372_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/01.CIR.0000084500.72232.8D","article-title":"Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease","volume":"108","author":"Nagueh","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejmg.2021.104372_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archpedi.1968.02100020377005","article-title":"Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease","volume":"116","author":"Noonan","year":"1968","journal-title":"Am. J. Dis. Child."},{"issue":"3\u20134","key":"10.1016\/j.ejmg.2021.104372_bib31","first-page":"110","article-title":"Effects of growth hormone treatment on left ventricular dimensions in children with Noonan's syndrome","volume":"56","author":"Noordam","year":"2001","journal-title":"Horm. Res."},{"key":"10.1016\/j.ejmg.2021.104372_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2019.2861","article-title":"Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM risk-kids)","author":"Norrish","year":"2019","journal-title":"JAMA cardiology"},{"issue":"6","key":"10.1016\/j.ejmg.2021.104372_bib33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-2265.2012.04456.x","article-title":"Rapid cardiovascular effects of growth hormone treatment in short prepubertal children: impact of treatment duration","volume":"77","author":"Nygren","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"30","key":"10.1016\/j.ejmg.2021.104372_bib34","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"Hypertrophic Cardiomyopathy Outcomes. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104372_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1472-8206.2010.00869.x","article-title":"Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death","volume":"24","author":"\u00d6stman-Smith","year":"2010","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.ejmg.2021.104372_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/euje.2000.0053","article-title":"A simple method for assessing the regression or progression of ventricular hypertrophy in the growing child and adult: the value of left ventricular wall-to-cavity ratios","volume":"2","author":"\u00d6stman-Smith","year":"2001","journal-title":"Eur. J. Echocardiogr."},{"key":"10.1016\/j.ejmg.2021.104372_bib40","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1111\/apa.16045","article-title":"Sudden death in childhood hypertrophic cardiomyopathy is best predicted by a combination of electrocardiogram risk-score and HCMRisk-Kids score","volume":"110","author":"\u00d6stman-Smith","year":"2021","journal-title":"Acta Paediatr."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104372_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2017-000658","article-title":"Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score","volume":"4","author":"\u00d6stman-Smith","year":"2017","journal-title":"Open Heart"},{"issue":"6","key":"10.1016\/j.ejmg.2021.104372_bib38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1017\/S1047951105001824","article-title":"Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly","volume":"15","author":"\u00d6stman-Smith","year":"2005","journal-title":"Cardiol. Young"},{"issue":"6","key":"10.1016\/j.ejmg.2021.104372_bib39","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/S0735-1097(99)00421-0","article-title":"A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment","volume":"34","author":"\u00d6stman-Smith","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejmg.2021.104372_bib41","series-title":"Growth Hormone Therapy in Pediatrics - 20 Years of KIGS","first-page":"347","article-title":"Short stature in noonan syndrome: results of growth hormone treatment in KIGS","author":"Otten","year":"2007"},{"issue":"7","key":"10.1016\/j.ejmg.2021.104372_bib42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/archdischild-2013-305047","article-title":"Cardiovascular disease in Noonan syndrome","volume":"99","author":"Prendiville","year":"2014","journal-title":"Arch. Dis. Child."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104372_bib43","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0735-1097(96)00591-8","article-title":"Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy","volume":"29","author":"Rishi","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.ejmg.2021.104372_bib44","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1210\/jc.2008-2094","article-title":"Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone","volume":"94","author":"Romano","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104372_bib45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/adc.2006.104547","article-title":"The natural history of Noonan syndrome: a long-term follow-up study","volume":"92","author":"Shaw","year":"2007","journal-title":"Arch. Dis. Child."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104372_bib46","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122","article-title":"Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with beta-blockade or verapamil","volume":"6","author":"Sherrid","year":"2013","journal-title":"Circulation. Heart failure"},{"issue":"3","key":"10.1016\/j.ejmg.2021.104372_bib47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/hrt.77.3.229","article-title":"A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants","volume":"77","author":"Skinner","year":"1997","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.ejmg.2021.104372_bib48","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1253\/jcj.57.1120","article-title":"Insulin-like growth factor I receptors in human cardiac myocytes and their relation to myocardial hypertrophy","volume":"57","author":"Toyozaki","year":"1993","journal-title":"Jpn. Circ. J."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104372_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-835368","article-title":"Acromegaly and heart failure: revisions of the growth hormone\/insulin-like growth factor axis and its relation to the cardiovascular system","volume":"4","author":"Twickler","year":"2004","journal-title":"Semin. Vasc. Med."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104372_bib50","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2012.04.018","article-title":"Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry","volume":"164","author":"Wilkinson","year":"2012","journal-title":"Am. Heart J."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972122100238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972122100238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:52:19Z","timestamp":1761709939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S176972122100238X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S176972122100238X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104372","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of cardiac aspects in children with Noonan syndrome \u2013 results from a European clinical practice survey among paediatric cardiologists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104372"}}